- Home
- PRLD vs NTRB Comparison
PRLD vs NTRB Comparison
Compare PRLD & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | NTRB |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 71.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | NTRB |
|---|---|---|
| Price | $1.68 | $4.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 3.7M | 23.1K |
| Earning Date | 11-12-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,500,000.00 | $2,578,059.00 |
| Revenue This Year | N/A | $560.75 |
| Revenue Next Year | N/A | $588.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 250.00 | 42.92 |
| 52 Week Low | $0.61 | $3.72 |
| 52 Week High | $4.22 | $11.78 |
Technical Indicators
Market Signals| Indicator | PRLD | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 32.14 |
| Support Level | $1.32 | $4.59 |
| Resistance Level | $1.69 | $4.99 |
| Average True Range (ATR) | 0.17 | 0.31 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 91.02 | 18.31 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.